Related references
Note: Only part of the references are listed.Random forests for high-dimensional longitudinal data
Louis Capitaine et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2021)
Cognitive trajectories of patients with focal ss-amyloid deposition
Si Eun Kim et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Individual changes in anthropometric measures after age 60 years: a 15-year longitudinal population-based study
Jie Guo et al.
AGE AND AGEING (2021)
Differentiating traits and states identifies the importance of chronic neuropsychiatric symptoms for cognitive prognosis in mild dementia
Lasse M. Giil et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)
Adding cognition to AT(N) models improves prediction of cognitive and functional decline
Deirdre M. O'Shea et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)
A Validation Study of the Remotely Administered Montreal Cognitive Assessment Tool in the Elderly Japanese Population
Kiyoko Iiboshi et al.
TELEMEDICINE AND E-HEALTH (2020)
Open Data Revolution in Clinical Research: Opportunities and Challenges
Mohamed H. Shahin et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease
Ali Ezzati et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Greater Variability in Cognitive Decline in Lewy Body Dementia Compared to Alzheimer's Disease
Lasse Melvaer Giil et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Modelling Decline in Cognition to Decline in Function in Alzheimer's Disease
Helene Karcher et al.
CURRENT ALZHEIMER RESEARCH (2020)
Machine learning for comprehensive forecasting of Alzheimer's Disease progression
Charles K. Fisher et al.
SCIENTIFIC REPORTS (2019)
Sigmoidal mixed models for longitudinal data
Ana W. Capuano et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2018)
The development of a stochastic mathematical model of Alzheimer's disease to help improve the design of clinical trials of potential treatments
Christoforos Hadjichrysanthou et al.
PLOS ONE (2018)
A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease
Guoqiao Wang et al.
STATISTICS IN MEDICINE (2018)
A Longitudinal Study of Neurocognition in Dementia with Lewy Bodies Compared to Alzheimer's Disease
Monica H. Breitve et al.
FRONTIERS IN NEUROLOGY (2018)
Trajectory and variability characterization of the Montreal cognitive assessment in older adults
Michael Malek-Ahmadi et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2018)
Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years
Carina Wattmo et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Continuous event monitoring via a Bayesian predictive approach
Jianing Di et al.
PHARMACEUTICAL STATISTICS (2016)
Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease
Richard E. Kennedy et al.
ALZHEIMERS & DEMENTIA (2014)
Predicting the Time to Clinically Worsening in Mild Cognitive Impairment Patients and its Utility in Clinical Trial Design by Modeling a Longitudinal Clinical Dementia Rating Sum of Boxes from the ADNI Database
Kaori Ito et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
An updated Alzheimer's disease progression model: incorporating non-linearity, beta regression, and a third-level random effect in NONMEM
Daniela J. Conrado et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2014)
Disease progression model for Clinical Dementia Rating-Sum of Boxes in mild cognitive impairment and Alzheimer's subjects from the Alzheimer's Disease Neuroimaging Initiative
Mahesh N. Samtani et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores
Monique M. Williams et al.
ALZHEIMERS & DEMENTIA (2013)
Understanding Placebo Responses in Alzheimer's Disease Clinical Trials from the Literature Meta-Data and CAMD Database
Kaori Ito et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models
Jorge L. Bernal-Rusiel et al.
NEUROIMAGE (2013)
Mixed model of repeated measures versus slope models in Alzheimer's disease clinical trials
M. C. Donohue et al.
JOURNAL OF NUTRITION HEALTH & AGING (2012)
Combining patient-level and summary-level data for Alzheimer's disease modeling and simulation: a beta regression meta-analysis
James A. Rogers et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2012)
Using cognitive decline in novel trial designs for primary prevention and early disease-modifying therapy trials of Alzheimer's disease
David Darby et al.
INTERNATIONAL PSYCHOGERIATRICS (2011)
Influence of apolipoprotein E ε4 on rates of cognitive and functional decline in mild cognitive impairment
Danielle C. Whitehair et al.
ALZHEIMERS & DEMENTIA (2010)
Item Analysis of ADAS-Cog: Effect of Baseline Cognitive Impairment in a Clinical AD Trial
Jeffrey J. Sevigny et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2010)
Longitudinal Modeling of Age-Related Memory Decline and the APOE ε4 Effect
Richard J. Caselli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Target symptoms and outcome measures: Cognition
Andrew Kirk
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2007)
The Alzheimer's disease assessment scale: Evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease
PM Doraiswamy et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2001)
Meta-analysis of continuous outcome data from individual patients
JPT Higgins et al.
STATISTICS IN MEDICINE (2001)
A method for estimating progression rates in Alzheimer disease
RS Doody et al.
ARCHIVES OF NEUROLOGY (2001)
Share Paper
